Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute
Vložit
- čas přidán 3. 02. 2023
- Omar Nadeem, MD, explains bispecific antibodies as an exciting new immunotherapy treatment option for patients with relapsed or refractory multiple myeloma. Learn more about our Multiple Myeloma Program. www.dana-farber.org/multiple-...
- Věda a technologie
DEAR EVERYONE AT DANA-FARBER CANCER INSTITUTE,
HAPPY NEW YEAR.
GOD BLESS YOU MY FRIENDS. I AM VERY PROUD OF YOU AND VERY HAPPY FOR YOU. I HOPE ALL OF YOUR DREAMS COME TRUE. I LOVE YOU. I LOVE DANA-FARBER CANCER INSTITUTE. 🙏
SINCERELY PETER